Zydus Gets Us Fda Approval To Market Generic Colestipol Hcl Tablets
Zydus Lifesciences Ltd. (Formerly Known As Cadila Healthcare Ltd.) Has Received Final Approval From The Us Fda To Market Generic Colestipol Hydrochloride Tablets In The Strength Of 1Mg.Colestipol Hydrochloride Tablets Are Indicated As Adjunctive Therapy To Diet For The Reduction Of Elevated Serum Total And Ldl-C In Patients With Primary Hypercholesterolemia (Elevated Ldl-C) Who Do Not Respond Adequately To Diet. Colestipol Hydrochloride Is A Highly Complex Macro Molecule Drug Substance With Little Or No Systemic Absorption.Zydus
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
